Ceftin (cefuroxime) for early Lyme disease

July 1997

Glaxo is now promoting Ceftin (cefuroxime) for early Lyme disease. It's the first antibiotic to be approved for this use.

But don't get too excited.

Ceftin isn't any more effective than doxycycline...and it costs 10 times more. Three weeks of Ceftin costs over $200.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote